Phibro Animal Health | PAHC - Current Assets


Phibro Animal Health reported $862.18M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Align Technology USD 2.62B 82.47M Dec/2025
ANI Pharmaceuticals USD 753.12M 54.72M Dec/2025
Assertio Holdings USD 263.57M 53.36M Sep/2025
Aurora Cannabis CAD 445.84M 22M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 524.67M 78.85M Dec/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Henry Schein USD 4.46B 69M Dec/2025
Idexx Laboratories USD 1.41B 63.23M Dec/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Nektar Therapeutics USD 281.36M 94.79M Sep/2025
Pacira USD 547.97M 14.78M Dec/2025
Phibro Animal Health USD 862.18M 26.39M Dec/2025
Prestige Brands USD 433.43M 63.98M Dec/2025
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
Zoetis USD 6.77B 185M Dec/2025